You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • THU0132 Comparison of dose escalation of infliximab and the addition of tacrolimus in rheumatoid arthritis patients with an inadequate response to infliximab and methotrexate combination therapy

Article info

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Posters
Rheumatoid arthritis – non-biologic treatment and small molecules
THU0132 Comparison of dose escalation of infliximab and the addition of tacrolimus in rheumatoid arthritis patients with an inadequate response to infliximab and methotrexate combination therapy

Authors

Citation

Yonemoto Y, Okamura K, Kaneko T, et al
THU0132 Comparison of dose escalation of infliximab and the addition of tacrolimus in rheumatoid arthritis patients with an inadequate response to infliximab and methotrexate combination therapy
Annals of the Rheumatic Diseases 2013;71:199-200.

Publication history

  • First published January 23, 2014.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions